Acarix AB (publ)
ACIXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.6M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20.60 Million |
|---|---|
| Enterprise Value | $-8,281,363.00 |
| Earnings per Share | $-0.04 |
| Beta | -0.22 |
| Outstanding Shares | 1,211,861,000 |
Return
| Return on Equity | -89.96% |
|---|---|
| Return on Assets | -82.49% |
| Return on Invested Capital | -87.22% |
Valuation & Multiples
| P/E Ratio | -5.5 |
|---|---|
| PEG | 20.92 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 22.02 |
| Enterprise Value to EBIT | -5.32 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$267,020
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$238,800
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Acarix AB (publ)
8 employees
CEO: Aamir Mahmood
Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product...